Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
K Mc Namara, H Alzubaidi… - … pharmacy research and …, 2019 - Taylor & Francis
Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores
the evidence surrounding community pharmacist interventions to reduce cardiovascular …
the evidence surrounding community pharmacist interventions to reduce cardiovascular …
Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review
Preventable diseases and late diagnosis of disease impose great clinical and economic
burden for health care systems, especially in the current juncture of rising medical …
burden for health care systems, especially in the current juncture of rising medical …
Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk
MA Strand, H Eukel, S Burck - Research in Social and Administrative …, 2019 - Elsevier
Background Prescription opioids are known to be highly addictive, contributing to the opioid
epidemic which continues to besiege victims in the United States. Pharmacists are …
epidemic which continues to besiege victims in the United States. Pharmacists are …
The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature
Abstract Background In Australia, community pharmacists are increasingly being integrated
into the healthcare system. A range of services in pharmacies are government-funded …
into the healthcare system. A range of services in pharmacies are government-funded …
Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community pharmacies' management
Background The current financial crisis is pressing health systems to reduce costs while
looking to improve service standards. In this context, the necessity to optimize health care …
looking to improve service standards. In this context, the necessity to optimize health care …
A cross-sectional survey of enhanced and extended professional services in community pharmacies: a pharmacy perspective
Background Community pharmacies provide enhanced (within current scope of practice)
and extended (requiring additional credentialing) services, for disease state management …
and extended (requiring additional credentialing) services, for disease state management …
Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional …
CE Amadi, FO Lawal, AC Mbakwem… - International journal of …, 2018 - Springer
Background Studies in international literature have shown that Community Pharmacists can
make considerable impact in controlling cardiovascular disease risk factors, especially …
make considerable impact in controlling cardiovascular disease risk factors, especially …
Successful implementation and provision of enhanced and extended pharmacy services
Background Careful planning is important for successful implementation and ongoing
provision of enhanced and extended pharmacy services. Objective To explore the factors …
provision of enhanced and extended pharmacy services. Objective To explore the factors …
Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery
A Bachyrycz, S Shrestha, BE Bleske… - Substance …, 2017 - journals.sagepub.com
Background: Given that opioid misuse/abuse and opioid overdose have reached epidemic
proportions in the United States, expansion of naloxone access programs are desperately …
proportions in the United States, expansion of naloxone access programs are desperately …
Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in …
Aims To compare the effectiveness of three pharmacy-based screening methods for type 2
diabetes (T2DM):(1) risk assessment (AUSDRISK) alone (Group A); AUSDRISK followed by …
diabetes (T2DM):(1) risk assessment (AUSDRISK) alone (Group A); AUSDRISK followed by …